A Clinician's Perspective on the Mechanism of β-Adrenoceptor Agonists in the Bladder.
作者信息
Lee Tack
机构信息
Department of Urology, Inha University Hospital, Incheon, Korea.
出版信息
Int Neurourol J. 2017 Mar 24;21(1):1-2. doi: 10.5213/inj.1720edi001.
Abstract
摘要
相似文献
1
A Clinician's Perspective on the Mechanism of β-Adrenoceptor Agonists in the Bladder.
Int Neurourol J. 2017 Mar 24;21(1):1-2. doi: 10.5213/inj.1720edi001.
2
Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome.
Eur Urol. 2016 Feb;69(2):311-23. doi: 10.1016/j.eururo.2015.09.007. Epub 2015 Sep 28.
3
Evidence for beta3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods.
J Pharmacol Exp Ther. 1999 Mar;288(3):1367-73.
4
Investigations into the presence of functional Beta1, Beta2 and Beta3-adrenoceptors in urothelium and detrusor of human bladder.
Int Braz J Urol. 2009 Jan-Feb;35(1):76-83. doi: 10.1590/s1677-55382009000100012.
5
Combination therapy with β3 -adrenoceptor agonists and muscarinic acetylcholine receptor antagonists: Efficacy in rats with bladder overactivity.
Int J Urol. 2016 May;23(5):425-30. doi: 10.1111/iju.13066. Epub 2016 Feb 18.
6
On the Site and Mechanism of Action of β-Adrenoceptor Agonists in the Bladder.
Int Neurourol J. 2017 Mar 24;21(1):6-11. doi: 10.5213/inj.1734850.425.
7
Modulation of nerve-evoked contractions by β3-adrenoceptor agonism in human and rat isolated urinary bladder.
Pharmacol Res. 2014 Feb;80:14-20. doi: 10.1016/j.phrs.2013.12.006. Epub 2013 Dec 28.
8
Noradrenaline-Induced Relaxation of Urinary Bladder Smooth Muscle Is Primarily Triggered through the β-Adrenoceptor in Rats.
Biol Pharm Bull. 2019;42(5):736-743. doi: 10.1248/bpb.b18-00903.
9
Selective β₃-adrenoceptor agonists for the treatment of overactive bladder.
J Urol. 2013 Oct;190(4):1173-80. doi: 10.1016/j.juro.2013.02.104. Epub 2013 Feb 28.
10
Relaxant effects of isoproterenol and selective beta3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders.
J Urol. 2001 Jan;165(1):240-4. doi: 10.1097/00005392-200101000-00071.
本文引用的文献
1
On the Site and Mechanism of Action of β-Adrenoceptor Agonists in the Bladder.
Int Neurourol J. 2017 Mar 24;21(1):6-11. doi: 10.5213/inj.1734850.425.
2
The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms.
Eur Urol. 2006 Sep;50(3):440-52; discussion 453. doi: 10.1016/j.eururo.2006.05.014. Epub 2006 May 19.
3
New pharmacologic targets for the treatment of the overactive bladder: an update.
Urology. 2004 Mar;63(3 Suppl 1):32-41. doi: 10.1016/j.urology.2003.10.005.
Zotero 插件